{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:49:18Z","timestamp":1793828958175,"version":"4.6.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jtct.2025.09.009","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T11:44:26Z","timestamp":1761651866000},"page":"65-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Heart of the Matter: Cardiac Toxicity in Allogenic Stem Cell Transplant with Post-Transplant Cyclophosphamide"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7192-5783","authenticated-orcid":false,"given":"Allison","family":"Gradone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satya","family":"Durugu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2156-904X","authenticated-orcid":false,"given":"Alicia","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boula","family":"Gattas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9354-2750","authenticated-orcid":false,"given":"Arpona Dev","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Filicko-O\u2019Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"O\u2019Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Storozynsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolores","family":"Grosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3088-4615","authenticated-orcid":false,"given":"Neal","family":"Flomenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0656-7385","authenticated-orcid":false,"given":"Usama","family":"Gergis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.jtct.2025.09.009_bib0001","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jtct.2025.09.009_bib0002","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1053\/bbmt.2002.v8.pm12171484","article-title":"Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide","volume":"8","author":"O\u2019Donnell","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"issue":"24","key":"10.1016\/j.jtct.2025.09.009_bib0003","doi-asserted-by":"crossref","first-page":"6283","DOI":"10.1182\/bloodadvances.2020003418","article-title":"How much has allogeneic stem cell transplant-related mortality improved since the 1980s? A retrospective analysis from the EBMT","volume":"4","author":"Penack","year":"2020","journal-title":"Blood Adv"},{"issue":"5","key":"10.1016\/j.jtct.2025.09.009_bib0004","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/ejh.14172","article-title":"Trends in underlying causes of death in allogeneic hematopoietic cell transplant recipients over the last decade","volume":"112","author":"S\u00f8borg","year":"2024","journal-title":"Eur J Haematol"},{"issue":"1","key":"10.1016\/j.jtct.2025.09.009_bib0005","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41409-019-0624-z","article-title":"Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors","volume":"55","author":"Styczy\u0144ski","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jtct.2025.09.009_bib0006","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"10.1016\/j.jtct.2025.09.009_bib0007","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1172\/JCI124218","article-title":"Posttransplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression","volume":"129","author":"Wachsmuth","year":"2019","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.jtct.2025.09.009_bib0008","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jaccao.2023.07.007","article-title":"Cardiovascular events after hematopoietic stem cell transplant","volume":"5","author":"Vasbinder","year":"2023","journal-title":"JACC CardioOncology"},{"issue":"10","key":"10.1016\/j.jtct.2025.09.009_bib0009","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1002\/1097-0142(19860515)57:10<2061::AID-CNCR2820571031>3.0.CO;2-H","article-title":"Cardiac complications after bone marrow transplantation. A report on a series of 63 consecutive transplantations","volume":"57","author":"Cazin","year":"1986","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.jtct.2025.09.009_bib0010","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1182\/bloodadvances.2022008792","article-title":"Incidence, risk factors, and impact of early cardiac toxicity after allogeneic hematopoietic cell transplant","volume":"7","author":"P\u00e9rez-Valencia","year":"2023","journal-title":"Blood Adv"},{"issue":"16","key":"10.1016\/j.jtct.2025.09.009_bib0011","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001220","article-title":"Cardiovascular management of patients undergoing hematopoietic stem cell transplantation: from pretransplantation to survivorship: a scientific statement from the American Heart Association","volume":"149","author":"Hayek","year":"2024","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jtct.2025.09.009_bib0012","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jaccao.2021.02.011","article-title":"Early cardiac toxicity associated with post-transplant cyclophosphamide in allogeneic stem cell transplantation","volume":"3","author":"Dul\u00e9ry","year":"2021","journal-title":"JACC CardioOncology"},{"issue":"24","key":"10.1016\/j.jtct.2025.09.009_bib0013","doi-asserted-by":"crossref","first-page":"5599","DOI":"10.1182\/bloodadvances.2021004846","article-title":"Cardiac toxicity after matched allogeneic hematopoietic cell transplant in the posttransplant cyclophosphamide era","volume":"5","author":"Yeh","year":"2021","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.jtct.2025.09.009_bib0014","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jaccao.2024.06.004","article-title":"Cardiovascular disease after hematopoietic stem cell transplantation in adults","volume":"6","author":"Gent","year":"2024","journal-title":"JACC CardioOncology"},{"issue":"Supplement 1","key":"10.1016\/j.jtct.2025.09.009_bib0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1182\/blood-2020-141416","article-title":"Incidence, risk factors and outcomes of cardiac toxicity in haploidentical peripheral stem cell transplantation with high dose cyclophosphamide","volume":"136","author":"Albanyan","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2025.09.009_bib0016","unstructured":"National Institutes of Health, National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) v 5.0. 2017.https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_5x7.pdf. Accessed August 1, 2025."},{"key":"10.1016\/j.jtct.2025.09.009_bib0017","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1237782","article-title":"The two-step approach to allogeneic hematopoietic stem cell transplantation","volume":"14","author":"Ibikunle","year":"2023","journal-title":"Front Immunol"},{"issue":"17","key":"10.1016\/j.jtct.2025.09.009_bib0018","doi-asserted-by":"crossref","first-page":"4732","DOI":"10.1182\/blood-2011-07-365338","article-title":"A 2-step approach to myeloablative haploidentical stem cell transplantation: a phase 1\/2 trial performed with optimized T-cell dosing","volume":"118","author":"Grosso","year":"2011","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.jtct.2025.09.009_bib0019","doi-asserted-by":"crossref","first-page":"1009.e1","DOI":"10.1016\/j.jtct.2024.07.019","article-title":"A tender reduced-intensity conditioning for the unfit: a novel 4 Gy total body irradiation-based conditioning followed by two-step haploidentical stem cell transplant, results of a prospective trial","volume":"30","author":"Bi","year":"2024","journal-title":"Transplant Cell Ther"},{"issue":"6","key":"10.1016\/j.jtct.2025.09.009_bib0020","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1053\/j.seminoncol.2012.09.006","article-title":"A two-step approach to allogeneic haploidentical hematopoietic stem cell transplantation","volume":"39","author":"Grosso","year":"2012","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jtct.2025.09.009_bib0021","unstructured":"Comprehensive Disease-specific Manuals. Center for International Blood and Marrow Transplant Research. https:\/\/www.nccn.org\/guidelines\/category_1. Accessed August 1, 2025."},{"issue":"4","key":"10.1016\/j.jtct.2025.09.009_bib0022","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1182\/blood-2012-03-418202","article-title":"A disease risk index for patients undergoing allogeneic stem cell transplantation","volume":"120","author":"Armand","year":"2012","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.jtct.2025.09.009_bib0023","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jtct.2025.09.009_bib0024","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","article-title":"Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors","volume":"18","author":"Glucksberg","year":"1974","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2025.09.009_bib0025","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.lfs.2018.12.018","article-title":"Molecular mechanism involved in cyclophosphamide-induced cardiotoxicity: old drug with a new vision","volume":"218","author":"Iqubal","year":"2019","journal-title":"Life Sci"},{"issue":"10","key":"10.1016\/j.jtct.2025.09.009_bib0026","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1002\/cncr.30534","article-title":"Cardiomyopathy in patients after posttransplant cyclophosphamide-based hematopoietic cell transplantation","volume":"123","author":"Lin","year":"2017","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.jtct.2025.09.009_bib0027","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/sj.bmt.1704763","article-title":"Cardiac toxicity of high-dose chemotherapy","volume":"35","author":"Morandi","year":"2005","journal-title":"Bone Marrow Transplant"},{"issue":"25","key":"10.1016\/j.jtct.2025.09.009_bib0028","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1161\/01.CIR.0000133187.74800.B9","article-title":"Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management","volume":"109","author":"Yeh","year":"2004","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jtct.2025.09.009_bib0029","doi-asserted-by":"crossref","first-page":"520","DOI":"10.6004\/jadpro.2023.14.6.5","article-title":"Post-transplant cyclophosphamide for the prevention of graft-vs.-host disease in allogeneic hematopoietic cell transplantation: a guide to management for the advanced practitioner","volume":"14","author":"Kachur","year":"2023","journal-title":"J Adv Pract Oncol"},{"issue":"7","key":"10.1016\/j.jtct.2025.09.009_bib0030","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s00277-016-2654-6","article-title":"The clinical features of fatal cyclophosphamide-induced cardiotoxicity in a conditioning regimen for allogeneic hematopoietic stem cell transplantation (allo-HSCT)","volume":"95","author":"Ishida","year":"2016","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.jtct.2025.09.009_bib0031","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2141.2008.07165.x","article-title":"Cardiac and cardiovascular consequences after haematopoietic stem cell transplantation","volume":"142","author":"Tichelli","year":"2008","journal-title":"Br J Haematol"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725014125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725014125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T06:12:33Z","timestamp":1768630353000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636725014125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2666636725014125"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2025.09.009","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Heart of the Matter: Cardiac Toxicity in Allogenic Stem Cell Transplant with Post-Transplant Cyclophosphamide","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2025.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of The American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}